Prosthetic  ||| S:0 E:11 ||| JJ
hip  ||| S:11 E:15 ||| JJ
infection  ||| S:15 E:25 ||| NN
due  ||| S:25 E:29 ||| JJ
to  ||| S:29 E:32 ||| TO
Listeria  ||| S:32 E:41 ||| NNP
monocytogenes ||| S:41 E:54 ||| NN
:  ||| S:54 E:56 ||| :
review  ||| S:56 E:63 ||| NN
of  ||| S:63 E:66 ||| IN
the  ||| S:66 E:70 ||| DT
literature  ||| S:70 E:81 ||| NN
and  ||| S:81 E:85 ||| CC
case  ||| S:85 E:90 ||| NN
report  ||| S:90 E:97 ||| NN
With  ||| S:97 E:102 ||| IN
the  ||| S:102 E:106 ||| DT
ageing  ||| S:106 E:113 ||| NN
of  ||| S:113 E:116 ||| IN
the  ||| S:116 E:120 ||| DT
population ||| S:120 E:130 ||| NN
,  ||| S:130 E:132 ||| ,
articular  ||| S:132 E:142 ||| JJ
prosthetic  ||| S:142 E:153 ||| JJ
replacements  ||| S:153 E:166 ||| NNS
are  ||| S:166 E:170 ||| VBP
becoming  ||| S:170 E:179 ||| VBG
more  ||| S:179 E:184 ||| JJR
and  ||| S:184 E:188 ||| CC
more  ||| S:188 E:193 ||| RBR
frequent ||| S:193 E:201 ||| JJ
.  ||| S:201 E:203 ||| .
One  ||| S:203 E:207 ||| CD
of  ||| S:207 E:210 ||| IN
the  ||| S:210 E:214 ||| DT
most  ||| S:214 E:219 ||| RBS
feared  ||| S:219 E:226 ||| JJ
complications  ||| S:226 E:240 ||| NN
is  ||| S:240 E:243 ||| VBZ
prosthetic  ||| S:243 E:254 ||| JJ
infection ||| S:254 E:263 ||| NN
,  ||| S:263 E:265 ||| ,
mostly  ||| S:265 E:272 ||| RB
due  ||| S:272 E:276 ||| JJ
to  ||| S:276 E:279 ||| TO
bacteria  ||| S:279 E:288 ||| NNS
of  ||| S:288 E:291 ||| IN
the  ||| S:291 E:295 ||| DT
cutaneous  ||| S:295 E:305 ||| JJ
flora ||| S:305 E:310 ||| NNS
.  ||| S:310 E:312 ||| .
Listeria  ||| S:312 E:321 ||| JJ
monocytogenes  ||| S:321 E:335 ||| NN
is  ||| S:335 E:338 ||| VBZ
rarely  ||| S:338 E:345 ||| RB
the  ||| S:345 E:349 ||| DT
cause ||| S:349 E:354 ||| NN
.  ||| S:354 E:356 ||| .
This  ||| S:356 E:361 ||| DT
paper  ||| S:361 E:367 ||| NN
describes  ||| S:367 E:377 ||| VBZ
the  ||| S:377 E:381 ||| DT
management  ||| S:381 E:392 ||| NN
of  ||| S:392 E:395 ||| IN
a  ||| S:395 E:397 ||| DT
hip  ||| S:397 E:401 ||| JJ
prosthetic  ||| S:401 E:412 ||| JJ
infection  ||| S:412 E:422 ||| NN
due  ||| S:422 E:426 ||| JJ
to  ||| S:426 E:429 ||| TO
Listeria  ||| S:429 E:438 ||| NNP
monocytogenes ||| S:438 E:451 ||| NN
.  ||| S:451 E:453 ||| .
The  ||| S:453 E:457 ||| DT
patient  ||| S:457 E:465 ||| NN
was  ||| S:465 E:469 ||| VBD
cured  ||| S:469 E:475 ||| VBN
with  ||| S:475 E:480 ||| IN
antimicrobial  ||| S:480 E:494 ||| JJ
therapy  ||| S:494 E:502 ||| NN
and  ||| S:502 E:506 ||| CC
a  ||| S:506 E:508 ||| DT
two-stage  ||| S:508 E:518 ||| JJ
exchange ||| S:518 E:526 ||| NN
.  ||| S:526 E:528 ||| .
This  ||| S:528 E:533 ||| DT
case  ||| S:533 E:538 ||| NN
report  ||| S:538 E:545 ||| NN
creates  ||| S:545 E:553 ||| VBZ
an  ||| S:553 E:556 ||| DT
opportunity  ||| S:556 E:568 ||| NN
to  ||| S:568 E:571 ||| TO
review  ||| S:571 E:578 ||| VB
the  ||| S:578 E:582 ||| DT
literature  ||| S:582 E:593 ||| NN
in  ||| S:593 E:596 ||| IN
the  ||| S:596 E:600 ||| DT
aim  ||| S:600 E:604 ||| NN
of  ||| S:604 E:607 ||| IN
determining  ||| S:607 E:619 ||| VBG
the  ||| S:619 E:623 ||| DT
risk  ||| S:623 E:628 ||| NN
factors  ||| S:628 E:636 ||| NNS
and  ||| S:636 E:640 ||| CC
the  ||| S:640 E:644 ||| DT
optimal  ||| S:644 E:652 ||| JJ
care ||| S:652 E:656 ||| NN
.  ||| S:656 E:658 ||| .
